Warfarin Sodium Articles
Boeh Ing's RE-LY trial completes enrollment
21 January 2008
FDA approves updated Coumadin information
20 August 2007
Medco and Mayo to study personalized medicine
11 December 2006
FDA c'tee backs DNA test for Coumadin Rxing
27 November 2006
Genelex launches warfarin safety test
6 November 2006
Barr settles Novartis suit for $22.5M
13 June 2006
Arixtra approved for two new indications
14 June 2004
Second FDA drug imports "blitz" finds 80% come from Canada
9 February 2004
Pharmion gains rights to Innohep from LEO
22 July 2002
Merck & Co warned over Vioxx promotion
25 September 2001
DuPont pays out $44.5 million in Coumadin lawsuit
9 August 2001
US state generics bill signed into law
5 June 2001
Florida Senate votes to allow generics
4 May 2001
Florida Senate panel backs generics
27 April 2001
Florida Senate panel backs formulary moves
26 February 2001
Florida moves on five neg formulary drugs
26 January 2001
US 1st-quarter results continue to flow in
3 May 2000
Florida progresses bill to boost generics
18 April 2000
Drugmakers lobby as Florida views Rx costs
28 March 2000
Senate interim health/aging report slams Florida State Negative Drug
14 September 1999
Texas BoP rejects curbs on generics
18 August 1999
P&U pursues novel antibiotics in $30m deal
7 April 1999
Analysts view FTC price-fixing probe
12 March 1999
DuPont has "poisoned" generic climate, says Barr
3 February 1999
DuPont Lawsuit Dropped
7 January 1999
Texas pharmacy reg ruled invalid
21 December 1998
US Insurers Ponder COX-2 Inhibitors
23 November 1998
Barr's Generic Warfarin Endorsed
12 August 1998
US Generics Sector "Lacks Political Clout"
16 June 1998
US Generics Sector "Lacks Political Clout"
12 June 1998
Barr Sues DuPont Merck Over Warfarin
11 March 1998
NY Legislature To Consider NTI Drugs
25 February 1998
Warfarin Plus Aspirin Cut Risk Of Heart Attack
11 February 1998
State Drops DuPont Merck-Backed Bill
3 February 1998
DuPont Merck-Backed Legislation Slammed
27 January 1998
Coumadin Battle Ends?
20 November 1997
Generic Warfarin
5 August 1997
Barr Labs Launches First Generic Warfarin In USA
31 July 1997
Coumadin launched in USA
15 May 1995
FDA Recommends Merck's Coumadin
6 March 1995
US ANTITHROMBOSIS MARKET FORECASTS
27 June 1994
DUPONT MERCK'S COUMADIN
9 May 1994
TRIAL FOR WARFARIN AND ASPIRIN COMBINATION
12 July 1993
Showing 1-48 of 48 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
